Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases

MYPI2025005794A0Undetermined Publication Date: 2021-07-15PROTAGONIST THERAPEUTICS INC +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025005794
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-01-15
Filing Date
2021-01-14
Publication Date
2021-07-15
Patent Text Reader

Abstract

The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases.
Need to check novelty before this filing date? Find Prior Art